Rapport Therapeutics, Inc.
RAPP
$14.77
-$0.16-1.07%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 260.45M | 285.38M | 305.28M | 320.66M | 336.14M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.69M | 100.00K | 300.00K | 900.00K | 1.30M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 105.00K | 5.49M | 4.22M | 4.38M | 3.23M |
| Total Current Assets | 270.24M | 290.97M | 309.80M | 325.94M | 340.67M |
|
|
|||||
| Total Current Assets | 270.24M | 290.97M | 309.80M | 325.94M | 340.67M |
| Net Property, Plant & Equipment | 14.22M | 10.87M | 4.97M | 5.02M | 5.24M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.03M | 211.00K | 160.00K | 189.00K | 189.00K |
| Total Assets | 285.50M | 302.05M | 314.93M | 331.14M | 346.10M |
|
|
|||||
| Total Accounts Payable | 3.18M | 2.14M | 1.95M | 1.32M | 1.88M |
| Total Accrued Expenses | 6.94M | 6.24M | 6.08M | 5.06M | 5.52M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.76M | 1.01M | 737.00K | 720.00K | 703.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.88M | 9.38M | 8.77M | 7.10M | 8.10M |
|
|
|||||
| Total Current Liabilities | 11.88M | 9.38M | 8.77M | 7.10M | 8.10M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 10.10M | 6.83M | 739.00K | 931.00K | 1.12M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 21.98M | 16.22M | 9.51M | 8.03M | 9.21M |
|
|
|||||
| Common Stock & APIC | 438.13M | 433.74M | 429.69M | 426.48M | 423.30M |
| Retained Earnings | -174.54M | -147.81M | -123.75M | -103.77M | -86.23M |
| Treasury Stock & Other | -76.00K | -95.00K | -522.00K | 400.00K | -183.00K |
| Total Common Equity | 263.51M | 285.84M | 305.43M | 323.11M | 336.89M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 263.51M | 285.84M | 305.43M | 323.11M | 336.89M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 263.51M | 285.84M | 305.43M | 323.11M | 336.89M |
|
|
|||||